vs
A.O.史密斯（AOS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
A.O.史密斯的季度营收约是Royalty Pharma plc的1.5倍（$912.5M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 13.7%，领先20.7%），Royalty Pharma plc同比增速更快（4.8% vs 0.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -3.4%）
A.O.史密斯是美国知名的家用及商用热水器、锅炉生产商，也是北美规模最大的热水器制造销售商，在亚洲市场还供应水处理和净化产品。公司在全球共有27个站点，包括北美5座生产基地，以及位于印度班加罗尔、中国南京、荷兰费尔德霍芬的工厂。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AOS vs RPRX — 直观对比
营收规模更大
AOS
是对方的1.5倍
$622.0M
营收增速更快
RPRX
高出4.8%
0.0%
净利率更高
RPRX
高出20.7%
13.7%
两年增速更快
RPRX
近两年复合增速
-3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $912.5M | $622.0M |
| 净利润 | $125.4M | $214.2M |
| 毛利率 | 38.4% | — |
| 营业利润率 | 17.9% | 62.4% |
| 净利率 | 13.7% | 34.4% |
| 营收同比 | 0.0% | 4.8% |
| 净利润同比 | 14.3% | 2.9% |
| 每股收益（稀释后） | $0.89 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AOSRPRX
| Q4 25 | $912.5M | $622.0M | ||
| Q3 25 | $942.5M | $609.3M | ||
| Q2 25 | $1.0B | $578.7M | ||
| Q1 25 | $963.9M | $568.2M | ||
| Q4 24 | $912.4M | $593.6M | ||
| Q3 24 | $902.6M | $564.7M | ||
| Q2 24 | $1.0B | $537.3M | ||
| Q1 24 | $978.8M | $568.0M |
净利润AOSRPRX
| Q4 25 | $125.4M | $214.2M | ||
| Q3 25 | $132.0M | $288.2M | ||
| Q2 25 | $152.2M | $30.2M | ||
| Q1 25 | $136.6M | $238.3M | ||
| Q4 24 | $109.7M | $208.2M | ||
| Q3 24 | $120.1M | $544.0M | ||
| Q2 24 | $156.2M | $102.0M | ||
| Q1 24 | $147.6M | $4.8M |
毛利率AOSRPRX
| Q4 25 | 38.4% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.3% | — | ||
| Q1 25 | 38.9% | — | ||
| Q4 24 | 37.1% | — | ||
| Q3 24 | 37.4% | — | ||
| Q2 24 | 38.7% | — | ||
| Q1 24 | 39.3% | — |
营业利润率AOSRPRX
| Q4 25 | 17.9% | 62.4% | ||
| Q3 25 | 18.6% | 70.1% | ||
| Q2 25 | 20.4% | 36.3% | ||
| Q1 25 | 19.1% | 94.0% | ||
| Q4 24 | 10.1% | 60.9% | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 21.9% | 50.2% | ||
| Q1 24 | 22.0% | -13.0% |
净利率AOSRPRX
| Q4 25 | 13.7% | 34.4% | ||
| Q3 25 | 14.0% | 47.3% | ||
| Q2 25 | 15.0% | 5.2% | ||
| Q1 25 | 14.2% | 41.9% | ||
| Q4 24 | 12.0% | 35.1% | ||
| Q3 24 | 13.3% | 96.3% | ||
| Q2 24 | 15.2% | 19.0% | ||
| Q1 24 | 15.1% | 0.8% |
每股收益（稀释后）AOSRPRX
| Q4 25 | $0.89 | $0.49 | ||
| Q3 25 | $0.94 | $0.67 | ||
| Q2 25 | $1.07 | $0.07 | ||
| Q1 25 | $0.95 | $0.55 | ||
| Q4 24 | $0.75 | $0.46 | ||
| Q3 24 | $0.82 | $1.21 | ||
| Q2 24 | $1.06 | $0.23 | ||
| Q1 24 | $1.00 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $193.2M | $618.7M |
| 总债务越低越好 | $155.0M | $9.0B |
| 股东权益账面价值 | $1.9B | $9.7B |
| 总资产 | $3.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.08× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AOSRPRX
| Q4 25 | $193.2M | $618.7M | ||
| Q3 25 | $172.8M | $938.9M | ||
| Q2 25 | $177.9M | $631.9M | ||
| Q1 25 | $200.2M | $1.1B | ||
| Q4 24 | $276.1M | $929.0M | ||
| Q3 24 | $255.6M | $950.1M | ||
| Q2 24 | $233.3M | $1.8B | ||
| Q1 24 | $303.1M | $843.0M |
总债务AOSRPRX
| Q4 25 | $155.0M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $193.2M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益AOSRPRX
| Q4 25 | $1.9B | $9.7B | ||
| Q3 25 | $1.8B | $9.6B | ||
| Q2 25 | $1.8B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $1.9B | $10.3B | ||
| Q3 24 | $1.9B | $10.3B | ||
| Q2 24 | $1.9B | $9.8B | ||
| Q1 24 | $1.9B | $9.9B |
总资产AOSRPRX
| Q4 25 | $3.1B | $19.6B | ||
| Q3 25 | $3.2B | $19.3B | ||
| Q2 25 | $3.2B | $18.3B | ||
| Q1 25 | $3.3B | $17.6B | ||
| Q4 24 | $3.2B | $18.2B | ||
| Q3 24 | $3.2B | $18.0B | ||
| Q2 24 | $3.2B | $17.7B | ||
| Q1 24 | $3.2B | $16.1B |
负债/权益比AOSRPRX
| Q4 25 | 0.08× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.10× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $165.5M | — |
| 自由现金流率自由现金流/营收 | 18.1% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 1.46× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $546.0M | — |
8季度趋势，按日历期对齐
经营现金流AOSRPRX
| Q4 25 | $183.1M | $827.1M | ||
| Q3 25 | $255.4M | $702.6M | ||
| Q2 25 | $139.6M | $364.0M | ||
| Q1 25 | $38.7M | $596.1M | ||
| Q4 24 | $221.9M | $742.5M | ||
| Q3 24 | $195.9M | $703.6M | ||
| Q2 24 | $57.4M | $658.2M | ||
| Q1 24 | $106.6M | $664.6M |
自由现金流AOSRPRX
| Q4 25 | $165.5M | — | ||
| Q3 25 | $240.6M | — | ||
| Q2 25 | $122.5M | — | ||
| Q1 25 | $17.4M | — | ||
| Q4 24 | $191.3M | — | ||
| Q3 24 | $163.4M | — | ||
| Q2 24 | $34.5M | — | ||
| Q1 24 | $84.6M | — |
自由现金流率AOSRPRX
| Q4 25 | 18.1% | — | ||
| Q3 25 | 25.5% | — | ||
| Q2 25 | 12.1% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 18.1% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 8.6% | — |
资本支出强度AOSRPRX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 2.2% | — |
现金转化率AOSRPRX
| Q4 25 | 1.46× | 3.86× | ||
| Q3 25 | 1.93× | 2.44× | ||
| Q2 25 | 0.92× | 12.06× | ||
| Q1 25 | 0.28× | 2.50× | ||
| Q4 24 | 2.02× | 3.57× | ||
| Q3 24 | 1.63× | 1.29× | ||
| Q2 24 | 0.37× | 6.45× | ||
| Q1 24 | 0.72× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOS
| North America Segment | $713.7M | 78% |
| Rest Of World | $158.3M | 17% |
| Other | $40.5M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
